Orosomucoid, an Acute Response Protein with Multiple Modulating Activities

Overview

Journal J Physiol Biochem

Specialties Biochemistry
Physiology

Date 2015 Feb 26

PMID 25711902

Citations 90

Authors

Zhumin Luo

Hong Lei

Yang Sun

Xia Liu

Ding-Feng Su

Affiliations

Soon will be listed here.

Abstract

Orosomucoid (ORM), or alpha-1-acid glycoprotein (AGP), is one of the acute-phase proteins. It has a molecular weight of 37-54 kDa, low pI of 2.8-3.8, and is heavily glycosylated (45 %). It is mainly synthesized by the liver, but many extrahepatic tissues have also been reported to produce ORM under myriad physiological and pathological conditions. Expression of the ORM gene is mainly controlled by a combination of the major regulatory mediators, such as glucocorticoids, interleukin (IL)-1, TNF-α, and IL-6. ORM has many activities including, but not limited to, acting as an acute-phase reactant and disease marker, modulating immunity, binding and carrying drugs, maintaining the barrier function of capillary, and mediating the sphingolipid metabolism. Its related receptor has been preliminarily explored in macrophages, neutrophils, and liver parenchymal cells, involving the membrane receptor CCR5, Siglect-5, and HBB, respectively. Additional activities of ORM such as regulating metabolism are currently being explored. Because of its regulation in liver diseases, cancer, and HIV, future ORM research is warranted.

Citing Articles

Characterisation and evaluation of predisposing factors for the development of xanthinuria in dogs with leishmaniosis under allopurinol therapy.

Oliveira S, Arenas C, Dominguez-Ruiz M, Prosper E, Dias M, Leal R Parasit Vectors. 2025; 18(1):98.

PMID: 40065388 PMC: 11895311. DOI: 10.1186/s13071-025-06731-0.

Proteomic analysis reveals candidate molecules to mediate cortical pathology and identify possible biomarkers in an animal model of multiple sclerosis.

Silva B, Leal M, Farias M, Nava A, Galvan D, Fernandez E Front Immunol. 2025; 16:1505459.

PMID: 40018028 PMC: 11864942. DOI: 10.3389/fimmu.2025.1505459.

Serum alpha-1 acid glycoprotein and gallstone risk in US adult women: a cross-sectional analysis of the NHANES.

Li X, He P Front Nutr. 2025; 12:1527717.

PMID: 40013166 PMC: 11860086. DOI: 10.3389/fnut.2025.1527717.

Multiomics Analysis Reveals Therapeutic Targets for Chronic Kidney Disease With Sarcopenia.

Wang M, You L, He X, Peng Y, Wang R, Zhang Z J Cachexia Sarcopenia Muscle. 2025; 16(1):e13696.

PMID: 39911133 PMC: 11799769. DOI: 10.1002/jcsm.13696.

Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2.

Liu X, Chen Z Am J Cancer Res. 2024; 14(11):5269-5285.

PMID: 39659916 PMC: 11626283. DOI: 10.62347/DEPW1251.

References

Huang Z, Ung T . Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics. Curr Drug Metab. 2012; 14(2):226-38. View

Lee Y, Choi J, Hwang I, Lee J, Lee J, Kim A . Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J Biol Chem. 2010; 285(29):22174-85. PMC: 2903347. DOI: 10.1074/jbc.M109.085464. View

Prowse K, Baumann H . Hepatocyte-stimulating factor, beta 2 interferon, and interleukin-1 enhance expression of the rat alpha 1-acid glycoprotein gene via a distal upstream regulatory region. Mol Cell Biol. 1988; 8(1):42-51. PMC: 443569. DOI: 10.1128/mcb.8.1.42-51.1988. View

Zhang S, Mark K . α1-Acid glycoprotein induced effects in rat brain microvessel endothelial cells. Microvasc Res. 2012; 84(2):161-8. PMC: 5412708. DOI: 10.1016/j.mvr.2012.05.003. View

Kremer J, Wilting J, Janssen L . Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev. 1988; 40(1):1-47. View

Yuasa I, Umetsu K, Vogt U, Nakamura H, Nanba E, Tamaki N . Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S. Hum Genet. 1997; 99(3):393-8. DOI: 10.1007/s004390050378. View

Wigmore S, Fearon K, Maingay J, Lai P, Ross J . Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol. 1997; 273(4):E720-6. DOI: 10.1152/ajpendo.1997.273.4.E720. View

Nishi K, Sakai N, Komine Y, Maruyama T, Halsall H, Otagiri M . Structural and drug-binding properties of alpha(1)-acid glycoprotein in reverse micelles. Biochim Biophys Acta. 2002; 1601(2):185-91. DOI: 10.1016/s1570-9639(02)00465-x. View

Mejdoubi N, Henriques C, Bui E, Porquet D . NF-kappaB is involved in the induction of the rat hepatic alpha1-acid glycoprotein gene by phenobarbital. Biochem Biophys Res Commun. 1999; 254(1):93-9. DOI: 10.1006/bbrc.1998.9903. View

10.

Yang T, Tsai W, Lee Y, Lei H, Lai M, Chen D . Purification and characterization of nucleolin and its identification as a transcription repressor. Mol Cell Biol. 1994; 14(9):6068-74. PMC: 359133. DOI: 10.1128/mcb.14.9.6068-6074.1994. View

11.

Petersen H, Nielsen J, Heegaard P . Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res. 2004; 35(2):163-87. DOI: 10.1051/vetres:2004002. View

12.

Kopecky Jr V, Ettrich R, Hofbauerova K, Baumruk V . Structure of human alpha1-acid glycoprotein and its high-affinity binding site. Biochem Biophys Res Commun. 2002; 300(1):41-6. DOI: 10.1016/s0006-291x(02)02765-1. View

13.

Mestriner F, Spiller F, Laure H, Souto F, Tavares-Murta B, Rosa J . Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism. Proc Natl Acad Sci U S A. 2007; 104(49):19595-600. PMC: 2148334. DOI: 10.1073/pnas.0709681104. View

14.

Ricca G, Hamilton R, McLean J, CONN A, Kalinyak J, Taylor J . Rat alpha 1-acid glycoprotein mRNA. Cloning of double-stranded cDNA and kinetics of induction of mRNA levels following acute inflammation. J Biol Chem. 1981; 256(20):10362-8. View

15.

Tokita K, Schmid K . VARIANTS OF ALPHA-1-ACID GLYCOPROTEIN. Nature. 1963; 200:266. DOI: 10.1038/200266a0. View

16.

Wiklund P, Pekkala S, Autio R, Munukka E, Xu L, Saltevo J . Serum metabolic profiles in overweight and obese women with and without metabolic syndrome. Diabetol Metab Syndr. 2014; 6(1):40. PMC: 3998195. DOI: 10.1186/1758-5996-6-40. View

17.

Kjeldsen J, Lauritsen K, de Muckadell O . Serum concentrations of orosomucoid: improved decision-making for tapering prednisolone therapy in patients with active inflammatory bowel disease?. Scand J Gastroenterol. 1997; 32(9):933-41. DOI: 10.3109/00365529709011205. View

18.

Ren F, Chen Y, Wang Y, Yan Y, Zhao J, Ding M . Comparative serum proteomic analysis of patients with acute-on-chronic liver failure: alpha-1-acid glycoprotein maybe a candidate marker for prognosis of hepatitis B virus infection. J Viral Hepat. 2009; 17(11):816-24. DOI: 10.1111/j.1365-2893.2009.01242.x. View

19.

Laine E, Couderc R, Roch-Arveiller M, Vasson M, Giroud J, Raichvarg D . Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein. Inflammation. 1990; 14(1):1-9. DOI: 10.1007/BF00914025. View

20.

Won K, Baumann H . The cytokine response element of the rat alpha 1-acid glycoprotein gene is a complex of several interacting regulatory sequences. Mol Cell Biol. 1990; 10(8):3965-78. PMC: 360907. DOI: 10.1128/mcb.10.8.3965-3978.1990. View